Cargando…
Mesenchymal stem cells as a therapeutic approach to glomerular diseases: benefits and risks
Most studies using adult stem cells (ASCs) and progenitor cells as potential therapeutics for kidney disorders have been conducted in models of acute kidney injury, where the damage mainly affects the tubulointerstitium. The results are promising, whereas the underlying mechanisms are still being di...
Autores principales: | Kunter, Uta, Rong, Song, Moeller, Marcus J, Floege, Jürgen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4089694/ https://www.ncbi.nlm.nih.gov/pubmed/25018904 http://dx.doi.org/10.1038/kisup.2011.16 |
Ejemplares similares
-
Platelet-derived growth factors (PDGFs) in glomerular and tubulointerstitial fibrosis
por: Ostendorf, Tammo, et al.
Publicado: (2014) -
Mesenchymal and induced pluripotent stem cell–based therapeutics: a comparison
por: Teale, Misha A., et al.
Publicado: (2023) -
Mesenchymal Stem Cells from Rats with Chronic Kidney Disease Exhibit Premature Senescence and Loss of Regenerative Potential
por: Klinkhammer, Barbara Mara, et al.
Publicado: (2014) -
Mesenchymal stem cells: A double‐edged sword in radiation‐induced lung injury
por: Yao, Yi, et al.
Publicado: (2017) -
Potential of mesenchymal stem cells in the repair of tubular injury
por: Imberti, Barbara, et al.
Publicado: (2011)